Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

What is the purpose of this trial?

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.

Participation Guidelines

Ages: 18 - 70 years

Gender: Both

University of Louisville

Start Date: 06/01/2017

End Date: 02/01/2018

Last Updated: 02/22/2018

Study HIC#: 1601017127

Get Involved

For more information about this study, contact:
Lindsey Fraczkiewicz
+1 203-785-3490

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Charles Matouk

Principal Investigator